Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,479 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Active, Not Recruiting

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

NCT06079879

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Palo Verde Hematology/ Oncology Center, Ltd. ( Site 3496) Glendale, Arizona, United States
  • Los Angeles Cancer Network ( Site 3491) Glendale, California, United States
  • Stanford Cancer Institute ( Site 0107) Stanford, California, United States
  • The Lundquist Institute ( Site 3423) Torrance, California, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

NCT06456346

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Palo Verde Cancer Specialists ( Site 0052) Glendale, Arizona, United States
  • Los Angeles Cancer Network ( Site 0025) Glendale, California, United States
  • Stanford Cancer Center ( Site 0024) Palo Alto, California, United States
  • Exempla Lutheran Medical Center ( Site 0014) Golden, Colorado, United States
View all 171 locations
View Trial Details
Active, Not Recruiting

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

NCT04106908

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Caen Study Site Caen, France
  • Clamart Study Site Clamart, France
  • Paris Study Site - Lariboisiere Paris, France
  • Paris Study Site - Necker Paris, France
View Trial Details
Active, Not Recruiting

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

NCT06883240

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Minnesota Medical Center Minneapolis, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors

NCT04431726

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of Colorado Denver, Children's Hospital Aurora, Colorado, United States
  • Tulane University Health Sciences Center New Orleans, Louisiana, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

NCT03588299

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital - Hematology / Oncology Little Rock, Arkansas, United States
  • C.S. Mott Children's Hospital - Hematology / Oncology Ann Arbor, Michigan, United States
  • UW Health Carbone Cancer Center Madison, Wisconsin, United States
  • SHATHD Spec. Hospi. for Active Treatm. of Haematol. Dis. EAD Sofia, Sofia City Province, Bulgaria
View all 13 locations
View Trial Details

Related conditions